Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study

Trial Profile

Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 06 Jun 2016

At a glance

  • Drugs Epoetin alfa (Primary)
  • Indications Encephalopathy
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms NEATO
  • Most Recent Events

    • 06 Jun 2016 New trial record
    • 02 May 2016 Primary endpoint has not been met. (Neurodevelopment at 12 months assessed by the Warner Initial Developmental Evaluation (WIDEA)), as per results published in the Pediatrics.
    • 02 May 2016 Primary endpoint has been met. (Neurodevelopment at 12 months assessed by the Alberta Infant Motor Scale (AIMS)), as per results published in the Pediatrics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top